The Impending Defeat of AIDS: A Glimmer of Hope on the Horizon
Since AIDS was first identified in the early 1980s, humanity has been fighting this global disease for more than four decades. In this long campaign, we have experienced numerous challenges, but also witnessed numerous hopes. With the rapid development of medical science and technology, the treatment of AIDS has made remarkable breakthroughs, so that people see the dawn of victory over this disease.
In 2020, the seventh person globally cured of AIDS was confirmed, marking a significant advance in our understanding of the complexity of HIV and how to eliminate the viral reservoir in the body. In addition, Gilead's new drug Lenacapavir, which is claimed to be able to achieve 100% blocking of HIV transmission, offers unprecedented hope for preventing the spread of AIDS. The emergence of this innovative treatment has undoubtedly injected a strong shot in the arm towards the goal of ending the AIDS epidemic completely by 2030.
In this fight against AIDS, the human strategy has also changed from the initial panic and inaction, to actively control and manage the disease, turning AIDS into a chronic disease. The advent of highly active antiretroviral therapy (HAART) has greatly extended the lives of AIDS patients and improved their quality of life. According to UNAIDS, since the 1980s, more than 85 million people have been infected with HIV worldwide and more than 40 million have died. However, since 2010, due to effective treatment and prevention measures, the number of new infections has fallen by 38% and the number of deaths by 51%.
Although we have made remarkable progress, the fight against AIDS still has a long way to go. Globally, tens of millions of people living with HIV are still in need of treatment, and new infections are continuing. However, with the emergence of new drugs such as Lenacapavir, and continued investment in HIV prevention and treatment worldwide, there is reason to believe that the end of AIDS will no longer be a distant dream.
Defeating AIDS would not only be a huge contribution to medical science, but also another major victory in the fight against the disease. This will inspire us to continue exploring the unknown, blazing new trails for global public health and creating a healthier and safer world for all life."
2026-07-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
DKSH to Distribute Exsymol's Silanols, Peptides, and Natural Active Ingredients in South Korea
-
Venator Launches TMP- and TME-Free Titanium Dioxide
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
Hengli Sanctions Spill Over: One Barrel of Iranian Crude Pulls an Aromatics Chain Into Risk
-
Chemicals Are Going Wild: Sulfur Surges 512%, Titanium Dioxide, Polyols and Sulfuric Acid Lose Control
-
Global Chemical Inventories Hit Critical Lows as Over 200 Chinese Companies Suspend Quotations
Recommend Reading
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
TDI Supply Tightens and Prices Surge: Can Cangzhou Dahua Reap the "Chemical Dividend"?
-
Nobian Becomes First European Chemical Company to Offer a Full Range of ISCC PLUS-Certified Chloromethanes
-
Sika's Margin Expands in the First Half of 2025
-
POND GROUP Acquires All Grace, Boosting Cosmetics Market Share by 20%
-
Strong Demand in Peak Season Supports EVA Market Prices in September
-
Recent EVA Market Prices Show a Slight Increase
-
Costs Decline, SBR Market Trend Weakens in September
-
In September, the butadiene rubber market showed a weak and fluctuating downward trend
-
September Polyethylene Slides Sharply Downward